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model was used. In this model a cohort of 10.000 bipolar I dis-
order patients was created using Dutch data on relevant patient
characteristics. This cohort was then used for the comparison of
the different treatment options. The treatment options compared
in the model were: 1). quetiapine & lithium; 2). olanzapine &
lithium; and 3). risperidon & lithium. For effectiveness four trials
on quetiapine were used. The effect measure was the number of
serious side effects. Serious side effects were: extra pyramidal
symptoms and/or more than 7% weight gain. Included costs
were: drug costs, hospital costs, hospital visits and laboratory
tests (2003 price levels). RESULTS: For the combination therapy
of quetiapine & lithium, the incremental net costs per serious
side effect averted were €1203 compared to risperdon & lithium
and €3481 compared to olanzapine & lithium. The effectiveness
on hospital stay is comparable over the three combination ther-
apies compared. CONCLUSIONS: Serious side effects may be
averted with quetiapine & lithium therapy at incremental costs.
Whether these costs are acceptable requires further research into
the ‘willingness to pay’ to avert one serious side effect.
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OBJECTIVES: To quantify the effect of galantamine on burden
of caregivers of patients with Alzheimer’s Disease (AD) enrolled
in INSPIRE (Investigation in a Naturalistic Setting of Patients
Initiated on Reminyl). METHODS: INSPIRE is a prospective,
observational study conducted across Canada in general practice
and specialist sites, involving 471 patients 65 years or older with
mild to moderate AD. Patient and caregiver demographics were
recorded at baseline, with effectiveness measured by the Mini-
Mental State Examination (MMSE) and Physician’s Clinical
Global Impression—Disease Status (CGI) at both baseline visit
and ﬁnal visit at 3 months. Caregiver stress was assessed using
the Zarit Burden Interview (ZBI). Analysis was based on two-
sided paired t-test. RESULTS: This preliminary analysis included
248 patients and caregivers, all of whom had completed the
study at time of analysis. Of these patients, the mean age was
80.6 ± 6.5, 61% were female, 54% had a high school degree or
less, and 74% lived with their spouse or partner. The mean age
of caregivers was 61.4 ± 14.6. The caregiver sample was pre-
dominately female (75%), most lived with the patient (54%),
and 42% employed on a full-time or part-time basis. At base-
line, the mean caregiver ZBI score was 21.5 ± 12.6. Signiﬁcant
improvement in caregiver burden (mean change 1.5 ± 8.4, p =
0.006) was shown after three months of galantamine treatment.
CONCLUSIONS: The efﬁcacy and safety of galantamine has
been demonstrated in multiple randomized, double-blind,
placebo-controlled trials in patients with mild-to-moderate AD.
This naturalistic study shows that galantamine signiﬁcantly
reduces burden among caregivers of patients with AD. Overall,
galantamine has a broad ranging beneﬁcial effect from both
patient and caregiver perspectives.
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OBJECTIVES: To determine the contribution of behavioural
symptoms to the costs associated with caring for patients with
dementia. METHODS: Data from the Canadian Outcomes
Study in Dementia (COSID), a 3-year prospective study of com-
munity-dwelling dementia patients was examined. Cognition
was assessed with the Mini-Mental State Examination (MMSE)
and behaviour with the Neuropsychiatry Inventory (NPI).
Resource utilization was evaluated monthly with caregiver-
completed resource use (RU) questionnaires, which included fre-
quency of community resource use (e.g., home care nurses,
Meals-on-Wheels, etc.), hospitalization and respite care, outpa-
tient visits and drug use (direct costs), as well as questions about
time away from work or leisure activities for both patient and
caregiver (indirect costs). Costs were calculated in 2000 Cana-
dian dollars. RESULTS: Five hundred dementia patients and
their caregivers who provided a minimum of 6 of 12 completed
RU questionnaires were included in this 1-year preliminary
analysis. At baseline, average age of patients was 76.3 (±6.3),
47% were male, and 82% were diagnosed with AD. Average
MMSE was 22.4 (±4.5) and average NPI 8.8 (±11.1; range
0–69). Total costs were estimated at $1298 per month ($113 for
medication costs, $237 for other direct costs, and $948 for indi-
rect costs). An analysis of covariance model, that included NPI,
MMSE, gender, age, marital status, dementia diagnosis, type of
residence, region of Canada, and number of medical co-
morbidities, showed that greater cognitive impairment, i.e.,
lower MMSE (F = 12.77, p < 0.0004), female gender (F = 9.31,
p = 0.0024) and non-AD dementia diagnosis (F = 6.27, p =
0.0126) were signiﬁcant covariates. After accounting for the
covariates, there was a signiﬁcant association between cost and
NPI (F = 22.46, p < 0.0001). The incremental cost of a one-point
increase in NPI score was $32 per month (95% CI $18–$45).
CONCLUSIONS: Behavioural and psychological symptoms of
dementia (BPSD) contribute signiﬁcantly to the total costs of
caring for community dwelling dementia patients.
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OBJECTIVES: To evaluate the HRQoL and burden of family
caregivers of dialysis patients and to analyze which variables
were associated to it. METHODS: A sample of 221 patient-carer
pairs, stratiﬁed by age and gender, was randomly selected from
14 dialysis units: 152 patients were on hemodialysis and 69 on
peritoneal dialysis. Patients and carers answered the SF-36,
obtaining Physical (PCS) and a Mental (MCS) Component
Summary scores standardized by age and gender, and the Duke-
UNK Functional Social Support (FSS). Carers also answered the
Caregiver Burden Interview of Zarit (ZS). RESULTS: Mean PCS
and MCS scores of carers were 48.4 ± 13.8 and 48.0 ± 11.3
respectively. Multiple regression analysis showed that the vari-
ables associated to lower PCS of the carer were: higher ZS and
older patient age (R2 = 0.15; p < 0.001). Variables associated to
lower MCS were: higher ZS and lower FSS of the carer, and
lower MCS of the patient (R2 = 0.29; p < 0.001). Variables asso-
ciated to a higher ZS of carers were: lower FSS and lower PCS
and MCS scores of the carer and higher age and lower PCS and
MCS scores of the patient (R2 = 0.49; p < 0.001). Carers with
a MCS =< 42 points (cutoff point associated with depression)
were 28.3% (95%CI = 22.4–34.8). Logistic regression analysis
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showed that variables associated to having a MCS =< 42 points
were: higher ZS and lower FSS of carer. CONCLUSIONS: The
HRQoL of caregivers is slightly worse than that of the general
population of the same age and gender. Physical health status is
more damaged in those caregivers suffering greater burden and
caring for older patients, and mental health status is more
damaged in those suffering greater burden, feeling lower social
support and caring for patients with worse mental health status.
The burden experienced by family carers depends on perceived
social support, age of patient and physical and mental health
status of carer and patient. A signiﬁcant percentage of carers
have depression which is associated to greater burden and lower
social support perceived.
PMH18
TRANSLATION, GREEK ADAPTATION AND
STANDARDIZATION OF THE VERONA SERVICE
SATISFACTION SCALE (VSSS-54): AN INSTRUMENT
PATIENTS’ SATISFACTION WITH MENTAL HEALTH SERVICES
Bletsa D, Kallinikou E, Mavreas V
University of Ioannina, School of Medicine, IOANNINA, Greece
OBJECTIVES: To describe the process of the adaptation and
standardization of the VSSS-54 (Verona Service Satisfaction
Scale) in Greece. METHODS: The methodology followed was
identical with this of the EPSILON study of schizophrenia. The
Italian Version of the VSSS-54 was ﬁrst translated into Greek,
by two bilingual translators. The resulting translation was then
back-translated into Italian by a professional translator. The
back-translation was checked by the authors of the VSSS and
compared with the original version. The content and the lan-
guage of the ﬁnal Greek translation were discussed in focus
groups, carried out in the Department of Psychiatry of the Uni-
versity General Hospital of Ioannina. The analysis of results of
the ﬁrst group (patients-relatives) as well as the second group
(professionals), allowed us to retrieve useful information related
to the adaptation of the Italian questionnaire VSSS into the
Greek language. The research was carried out in two outpatient
psychiatric services in Athens and in Ioannina. A total of 150
patients were selected (87 women, 63 men), whose age ranged
from 18 to 65 (M = 43.7, SD = 11.45). Among them 64 (43%)
had diagnosis of schizophrenia or other psychosis, 74 (49%)
affective disorder and 10 (6.6%) anxious disorders. The relia-
bility analyses are based on classical test theory. Reliability 
measures used are Cronbach’s a, Cohen’ s weighted k, and the
intra-class correlation coefﬁcient. RESULTS: The a coefﬁcient
for the VSSS total score was 0.917 (95%Cl 0.878–0.948). Test-
retest reliability was proven to be good. CONCLUSIONS: The
psychometric properties of the Greek version of the VSSS are
similar to those of the Italian and the other European versions
of the instrument, outcome which proves that it is a valid and
reliable instrument to use in the Greek context.
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OBJECTIVES: The use of novel antipsychotics (NAs) has
steadily increased and they are now the dominant choice among
antipsychotic agents. Antipsychotics are often prescribed in
elderly patients who become agitated or develop psychotic symp-
toms. New indications, primarily mood disorders, have also 
contributed to growing use. We set out to determine overall pre-
scribing frequency of NAs and changes in patterns of use for spe-
ciﬁc NAs in elderly patients admitted to a psychiatric hospital
over 5-years. METHODS: This was a retrospective analysis of
elderly (≥65 years) patients admitted to a psychiatric hospital
from ﬁscal year (FY) 2000–2004. All NAs prescribed during each
patient admission were identiﬁed from the pharmacy database.
Patient demographics, length of stay, and diagnoses were col-
lected for each patient admission. Descriptive statistics were per-
formed as well as a multivariate logistic regression to determine
factors that inﬂuenced NA prescribing. RESULTS: There were
2179 elderly patients admitted during the 5-year timeframe. The
mean age was 78 years, 63% were female, and 83% were white.
The average length of stay was 21 days and did not differ across
FYs. The proportion of hospital admissions where NAs were pre-
scribed in elderly patients increased signiﬁcantly (p < 0.001) over
the ﬁve-year period from 50% in FY 2000 to 63% in FY 2004.
Prescribing increased the most for quetiapine: 13% in FY 2000
to 27% in FY 2004. Independent factors associated with NA pre-
scribing were female sex (OR = 1.2, p = 0.05), Alzheimer’s
Disease/dementia diagnosis (OR = 1.9, p < 0.001), psychotic 
disorder diagnosis (OR = 4.7, p < 0.001) and increasing FY (OR
= 1.2, p < 0.001). Black race (OR = 0.8) and depression 
diagnosis (OR = 0.5) were associated with a reduced odds of
receiving a NA. CONCLUSIONS: NA prescribing in elderly
inpatients has increased signiﬁcantly in the last ﬁve years, with
quetiapine use increasing the most. Diagnoses of Alzheimer’s
Disease/dementia and psychotic disorders were independent pre-
dictors of NA use.
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It’s widely assumed that patients rehabilitate better in commu-
nity than in inpatient facilities. Moreover deinstitutionalization
saves health care costs. However, deinstitutionalization may
reduce patients’ compliance and entail substantial risks since
patients with schizophrenia have increased risk of becoming
violent and/or committing suicide. OBJECTIVE: Investigate the
relation of risk of harming self and/or others and symptoms in
schizophrenia to improve prevention and diagnosis of patients
who present a risk to society. METHOD: The association
between Positive and Negative Symptom Scale (PANSS) and risk
of harming self/others as measured by Camberwell Assessment
of Need (CAN) score was assessed using logistic regression (N =
171). Standard statistical tests were applied to evaluate the sig-
niﬁcance of relationship between total PANSS, sub-scores (neg-
ative, positive, general psychopathology) and all 30 items, and
risk of harming self/others. Receiver Operating Characteristic
(ROC)-curves were used to assess discrimination. Calibration
was quantiﬁed by the slope of the prognostic index. Model para-
meters were internally validated by bootstrapping. RESULTS:
PANSS is signiﬁcantly associated with risk of harming self/others
with an area under the curve (AUC) of ROC of 0.763. Patients
with total PANSS of 70 and 80 have a 6.8% (95% CI
3.6%–12.4%) and 9.8% (95% CI 5.1%–17.8%) risk of harming
self and/or others respectively. The models including PANSS neg-
ative sub-score or PANSS blunted affect item had an AUC of
ROC of 0.784 and 0.786 respectively for patients’ risk of
harming self and/or others. Discussion: Reducing (negative)
symptoms, especially blunted affect, may reduce patient’s risk of
